An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas

Figure 7

Constructing a nomogram model integrating the six-gene risk signature and clinical factors. (a, b) Univariate and multivariate Cox analyses showed that the risk signature was significantly correlated with OS in both CGGA_693 and TCGA cohorts. (c) Nomogram model for predicting the 1-, 3-, and 5-year survival in IDH-mutant LGGs. (d–f) Calibration curve of the nomogram for predicting the probability of OS at 1, 3, and 5 years. (g–i) The time-dependent AUC value of the six-gene signature and other clinical factors in the three independent cohorts.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)